Difficulties in interpreting specimens after neoadjuvant hormonal therapy and radiation with illustration of neuroendocrine differentiation

Molecular Urology

Volumn 4, Issue 3, 2000, Pages

  Civantos, F ^a   Stone, N ^a   Grignon, D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTIANDROGEN; CHROMOGRANIN; KERATIN; PROSTATE SPECIFIC ANTIGEN; SYNAPTOPHYSIN;

CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; CHEMOTHERAPY, ADJUVANT; CHROMOGRANINS; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PHOSPHOPYRUVATE HYDRATASE; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; SEROTONIN; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; UROTHELIUM;

EID: 0033755789     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Histopathological effects of androgen deprivation in prostatic cancer
2. Pathology of androgen deprivation therapy in prostate carcinoma
3. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostatic cancer
4. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
5. Histologic basis and optimal duration for neoadjuvant androgen deprivation therapy
6. Surgical pathology examination of the prostate gland: Practice survey by American Society of Clinical Pathologists
7. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures
8. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: Report of 30 cases
9. Neoadjuvant hormonal therapy prior to radical prostatectomy
10. Biochemical and pathological effects of 8 months of neo-adjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer
11. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma
12. Prostatic carcinoma: Histological and immunological factors affecting prognosis
13. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
14. Relation of endocrineparacrine cell to cell proliferation in normal hyperplastic and neoplastic human prostate
15. Neuroendocrine differentiation in prostatic adenocarcinoma is not an independent prognostic indicator
16. Histological and immunophenotypic features after prostate seed implants